Arcturus Therapeutics (NASDAQ:ARCT) and CSL Limited (OTCQX:CSLLY) (OTCQX:CMXHF) announced Tuesday that the EU drug regulator, the European Medicines Agency (EMA), validated the marketing application ...

On Tuesday, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) announced that it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in cystic fibrosis (CF) for ARCT-032 at ...

Dec 13 (Reuters) - India's markets regulator on Friday proposed a framework to allow retail investors to participate in algorithmic trading through stock brokers. In 2008, the Securities and Exchange ...